Sukhani told CNBC-TV18, "If you know something about the company or the investor has some inside information one can go and buy Suven Life Sciences even now, it's not at a circuit. But otherwise if you own it then hold it, I wouldn't suggest buying."
At 11:15 hrs the share was quoting at Rs 30.80, up Rs 3.40, or 12.41% with volumes of 1,405,757 shares. Market capitalisation stands at Rs 356.89 crore.
The company's trailing 12-month (TTM) EPS was at Rs 0.50 per share. The stock's price-to-earnings (P/E) ratio was 61.60. The latest book value of the company is Rs 9.88 per share. At current value, the price-to-book value of the company was 3.12. The dividend yield of the company was 0.81%.
